TrialEuropean child & adolescent psychiatry2009

Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents.

Pär Svanborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.